Wednesday’s ‘Behind the Mystery’ segment is designed to inspire and inform in equal measures.
Photo 51 will offer services from market access strategy to creative campaigns for gene and cell therapies.
Patient advocates called on pharma to collaborate and inform more effectively.
Find out which submissions were the most compelling.
Vote for the most compelling creative by Thursday, February 27.
We analyze three winning rare disease campaigns that illustrate the challenges and opportunities that come with operating in such a difficult realm.
Submissions are open until Wednesday, February 19 at 5:00 p.m. ET.
A collaboration between a foundation and a health-tech company has yielded more than viable drug candidates. It has set a new standard for patients’ role in research.
Eisai tapped into voice technology to give children with Lennox-Gastaut Syndrome and their caregivers a way to play.
The company’s new kid-focused video series is about rare disease PH1.
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.